Becker's Healthcare July 10, 2024
Rylee Wilson

The Federal Trade Commission is preparing to sue UnitedHealth Group, CVS Health and the Cigna Group over their pharmaceutical benefit managers’ business practices, The Wall Street Journal reported July 10.

The FTC published a report on July 9 alleging PBMs favor their own pharmacies and “wield enormous power” over the types of drugs patients can access and the prices they pay.

UnitedHealth Group’s OptumRx, Cigna’s Express Scripts and CVS’ Caremark handle 79% of prescriptions in the U.S., according to the FTC report.

Sources familiar with the lawsuit told the Journal the FTC is preparing to file a challenge related to rebates PBMs negotiate with drug manufacturers. The commission is also investigating drug manufacturers’ role in the negotiations,...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Govt Agencies, Pharma, Pharma / Biotech, Survey / Study, Trends
First Comprehensive Review of SMA Drugs Offers Long-Term Insights, Outcome Gaps
Drugmaker might be 1st healthcare company to top $1 trillion valuation
Prescription drug spending grew even after rebates
Remote monitoring and pharmacist helps improve hard-to-control blood pressure, research shows
Pharma Pulse 9/5/24: Legal Advice for DSCSA Compliance Teams, Pharmacy Students Discuss Learning Through Social Media Platforms & more

Share This Article